Rajnish Wellness MD, chairman, board of directors and AGM
BSE: 541601Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹0.34.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹35 Cr3,472nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 1 Jun 2026
- 0.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −8.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 1 Jun 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 26,23,249
Rajnish Wellness board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorRAJNISHKUMAR SURENDRAPRASAD SINGH
- Company Secretary and Compliance OfficerAnupma Kashyap
5 directors3 independent1 executive1 non-executive
- RAJNISHKUMAR SURENDRAPRASAD SINGH · Chairperson and managing directorExecutive · joined Jun 2015 · reappointed Sep 2023 · 2 listed boards · 1 committee seat
- MONAM KAPOORIndependent · joined Feb 2022 · 53 months as independent · 6 listed boards · 5 as independent · 8 committee seats, 3 as chair
- PREETIIndependent · joined Sep 2022 · 46 months as independent · 4 listed boards · 4 as independent · 3 committee seats, 3 as chair
- SWATI JAINIndependent · joined May 2023 · 38 months as independent · 6 listed boards · 6 as independent · 3 committee seats, 4 as chair
- SALONI MEHRANon-executive · joined May 2023 · 7 listed boards · 6 as independent · 6 committee seats, 3 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 30 May 20265 of 5 present3 independent · 111 days in between
- 7 Feb 20265 of 5 present3 independent
Audit Committee
Chair PREETI
MONAM KAPOOR, RAJNISHKUMAR SURENDRAPRASAD SINGH
- 30 May 20263 of 3 present2 independent · 111 days in between
- 7 Feb 20263 of 3 present2 independent
Nomination and remuneration committee
Chair PREETI
MONAM KAPOOR, SALONI MEHRA
- 7 Feb 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair PREETI
MONAM KAPOOR, SALONI MEHRA
- 7 Feb 20263 of 3 present2 independent
Risk Management Committee
Chair RAJNISHKUMAR SURENDRAPRASAD SINGH
PREETI, MONAM KAPOOR
- 30 Mar 20263 of 3 present2 independent · 50 days in between
- 7 Feb 20263 of 3 present2 independent
Independent directors meeting
- 7 Feb 20263 of 3 present3 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Motilal & Associates LLPPeer-review certificate valid to Aug 2026
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Rajnish Wellness AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Rajnish Wellness share news and announcements
Annual general meeting, 26 Sep 2026
1,59,409 shareholders on the register on 19 Sep 2026; present: 1 promoter and 89 others; votes counted by KUNAL SAPKAL / HSPN AND ASSOCIATES.The company's voting result (opens in a new tab)
- To receive, consider and adopt the audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2026 and the Reports of the Directors and the Auditors thereonOrdinary99.87% for0.13% against
Against: promoters 0.00% · institutions 0.00% · other public 6.47%
Turnout: all 9.34% · promoters 100.00% · institutions 0.00% · other public 0.20%
- TO RE-APPOINT MR. RAJNISHKUMAR S. SINGH (DIN: 07192704) WHO RETIRES BY ROTATION & BEING ELIGIBLE OFFERS HIMSELF FOR RE-APPOINTMENT AS DIRECTOROrdinaryPromoters have an interest in it93.53% for6.47% against
Against: promoters 0.00% · institutions 0.00% · other public 6.47%
Turnout: all 0.18% · promoters 0.00% · institutions 0.00% · other public 0.20%
- TO APPROVE RELATED PARTY TRANSACTIONS UP TO Rs.10 CRORESOrdinaryPromoters have an interest in it93.47% for6.53% against
Against: promoters 0.00% · institutions 0.00% · other public 6.53%
Turnout: all 0.18% · promoters 0.00% · institutions 0.00% · other public 0.20%
- TO APPROVE THE TRANSACTIONS WITH THE COMPANY'S RELATED PARTIESOrdinaryPromoters have an interest in it93.47% for6.53% against
Against: promoters 0.00% · institutions 0.00% · other public 6.53%
Turnout: all 0.18% · promoters 0.00% · institutions 0.00% · other public 0.20%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Fines
Reported in the filing for the quarter to Jun 2026.
- Fine or penaltyBSESince 30 Jun 2026₹5,900
Fines as per SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on July 11, 2023 and last updated on January30,2026 (Chapter VII (A)-Penal Action for Non-Compliance
Regulation 23 (9) Non-compliance withthe requirement todisclose related partytransactions in theformat as specifiedand within theprescribed timeline.
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Sep 2025. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far. A statement's amounts are left out where the raise it states is more than ten times everything the company owns, a figure typed at the wrong scale.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Rights IssuesAug 2025 | – | Acquisition of Milan Trading Co | – | – | No |
| Rights IssuesAug 2025 | – | Augmentation of Working Capital | – | – | No |
| Rights IssuesAug 2025 | – | General Corporate Purposes | – | – | No |